SAN FRANCISCO — ICAAC 2012 — Trius Therapeutics, Inc. announced today that the results of multiple studies from its drug development programs, including its lead antibiotic drug candidate tedizolid phosphate …
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Top 100 Pharmaceutical Enterprises and the Listed Company SZ.002020